19573-01-4 Usage
General Description
Byakangelicin is a chemical compound found in the roots of the medicinal plant Angelica gigas. It belongs to the class of organic compounds known as coumarins, which are known for their antioxidant and anti-inflammatory properties. Byakangelicin has been found to possess significant cytotoxic and anti-tumor activities in various cancer cell lines, including breast and lung cancer. It has also shown potential in promoting bone growth and could be beneficial in the treatment of osteoporosis. Byakangelicin is also being studied for its potential use in the development of new therapeutic agents for various diseases, and its pharmacological properties make it a promising candidate for further research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 19573-01-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,5,7 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 19573-01:
(7*1)+(6*9)+(5*5)+(4*7)+(3*3)+(2*0)+(1*1)=124
124 % 10 = 4
So 19573-01-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3/t11-/m1/s1
19573-01-4Relevant articles and documents
Benzofuran and coumarin derivatives from the root of Angelica dahurica and their PPAR-γ ligand-binding activity
Matsuo, Yukiko,Yamaguchi, Emi,Hakamata, Ryo,Ootomo, Kanae,Takatori, Kazuhiro,Fukaya, Haruhiko,Mimaki, Yoshihiro
, (2020/02/26)
A phytochemical investigation of the root of Angelica dahurica led to the isolation of benzofuran and coumarin derivatives. This is the first report of the isolation and identification of three furanocoumarin sulfates from A. dahurica root. The structures of a total of twelve undescribed compounds were determined by extensive spectroscopic analysis, including 2D NMR data, hydrolysis, and solvolysis, followed by either physicochemical and spectroscopic data or X-ray crystallographic analysis. The isolated compounds were evaluated for their PPAR-γ ligand-binding activity, and six compounds showed significant PPAR-γ ligand-binding activity. In particular, the undescribed benzofuran derivative, 3-[6,7-furano-9-hydroxy-4-(2″,3″-dihydroxy-3″-methylbutyloxy)]-phenyl propionic acid, exhibited the most potent PPAR-γ ligand-binding activity and accumulated intracellular lipid in 3T3-L1 cells.
